Are You a Good Fit for the pTau-217 Alzheimer’s Blood Test?

When your memory starts to change, a question that may come up is: “Is this Alzheimer’s disease, or something else?” For many people, that concern shows up as memory loss or other cognitive changes that can have many causes, including Alzheimer’s disease and other forms of dementia.

Until recently, getting a clear answer often required more invasive or harder-to-access testing such as a spinal tap or specialized brain imaging. Now, newer options, like a blood test for memory loss concerns, can help doctors assess whether Alzheimer’s-type changes may be present using a standard blood draw.

Advanced Medical Care offers the pTau-217 blood test as part of a comprehensive neurology evaluation for patients with cognitive concerns. However, this test is not meant to be used alone, it’s one tool that can support diagnosis and next steps when combined with a full evaluation that includes your symptoms, medical history, and other testing when needed.

What is the pTau-217 Alzheimer’s Blood Test?

pTau-217 is short for phosphorylated tau 217. Tau is a protein found in the brain, and in Alzheimer’s disease it can become altered in specific ways. One of those Alzheimer’s-associated changes is pTau-217, which can sometimes be measured with a blood test.

Studies show pTau-217 tends to be higher in people with Alzheimer’s-type changes in the brain. In plain terms, this test doesn’t measure “how much tau” you have overall. It looks for a specific Alzheimer’s-related form of tau that can help your neurology team judge whether symptoms are more consistent with Alzheimer’s disease or another cause of memory problems.

Who Might Benefit From a pTau-217 Alzheimer’s Blood Test?

The pTau-217 Alzheimer’s blood test may be helpful for adults who are experiencing or reporting cognitive changes, including:

• People with new or worsening memory concerns
• Patients already being evaluated for dementia
• Patients referred by a PCP who want a more complete specialist evaluation
• Patients being considered for Alzheimer’s-directed therapies, when appropriate, as part of a comprehensive plan

An important note about this blood test is that it’s not meant to be a general screening test that’s given to anyone “just to check.” It’s used when there are specific symptoms or concerns that warrant a deeper evaluation, and when the results would actually help guide next steps.

A neurologist can determine whether this test makes sense based on symptoms, medical history, medications and the broader evaluation. Many people search for a “blood test for dementia” when memory and thinking changes start to affect daily life. 

In reality, dementia can have many causes, which is why Advanced Medical Care uses pTau-217 as part of a full neurology evaluation to help determine whether Alzheimer’s disease is more likely and what the next steps should be. It’s most useful when interpreted alongside things like history, cognitive testing, and other labs or imaging when needed.

Benefits of the pTau-217 Blood Test for Patients

Many patients feel relieved knowing this test is a simple blood draw rather than more invasive procedures like:

• Spinal tap (lumbar puncture): collects cerebrospinal fluid (CSF) to measure Alzheimer’s-related markers
• Specialized PET imaging: scans that can look for amyloid or tau changes in the brain (availability and insurance coverage can vary)
• Multiple-step referral pathways: some patients need to be sent to outside centers for these tests, which can add delays

In some situations, having this option available can also help the care team decide whether more invasive or harder-to-access testing is even necessary.

This test can also support earlier, clearer answers when it’s used as part of a full evaluation. Alzheimer’s-related changes may begin years before the symptoms become severe, and a blood-based biomarker like pTau-217 can help clinicians find out whether Alzheimer’s-type changes are more likely. This gives patients and families time to have conversations about planning, support and treatment options when appropriate.

Just as important, our team does not treat this as “just a lab result.” The pTau-217 test is interpreted within a comprehensive neurology evaluation that may include:

• Symptom history (including patient and family input)
• Cognitive screening or testing when appropriate
• Imaging and other labs when needed
• Review of health factors that can affect memory (sleep, mood, medications, vascular risk, etc.)

The goal is to arrive at a clear diagnosis and a plan, not simply give a number on a report.

Benefits of pTau-217 Testing for Providers

Primary care providers and referring clinicians often see patients with memory complaints, but the underlying causes can vary widely. When used appropriately within a neurologist-led evaluation, a pTau-217 result can help clarify which patients are more likely to have Alzheimer’s-type pathology versus those who may need a different diagnostic path.

Ways this can help in practice include:

• Supporting more efficient triage of patients with cognitive symptoms
• Helping prioritize referrals for patients who may need more urgent specialist follow-up
• Providing additional clinical clarity alongside history, cognitive testing, imaging, and other labs when appropriate

Blood-based biomarkers are also increasingly used in specialty settings to support treatment decisions and monitoring in select patients, particularly when Alzheimer’s-directed therapies are being considered and followed over time.

At Advanced Medical Care, we also provide a straightforward local referral pathway for providers in Queens and Brooklyn. Instead of sending patients to distant centers or navigating months-long waitlists, PCPs can refer to our neurology team for a comprehensive evaluation that can incorporate pTau-217 testing when clinically appropriate.

pTau-217 Alzheimer’s Blood Tests in Queens and Brooklyn

At Advanced Medical Care, our neurology team helps patients get clear answers about memory and cognitive concerns, including access to an Alzheimer’s blood test in Queens and Brooklyn when clinically appropriate and as part of a comprehensive evaluation that considers your symptoms, medical history, cognitive testing and any additional labs or imaging needed.

Depending on your needs, your evaluation may include:

• Detailed symptom history (including family input when helpful)
• Cognitive screening or more formal cognitive testing
• Review of medications and health factors that can affect memory (sleep, mood, vascular risk, etc.)
• Additional labs or imaging when clinically appropriate
• Next-step guidance and follow-up care planning

If you’re concerned about memory changes or want a neurology evaluation, call us at 347-571-9389 (Queens) or 929-552-2973 (Brooklyn) to schedule an appointment, or book online to get started.

pTau-217 Alzheimer’s Blood Tests Frequently Asked Questions

Is the pTau-217 blood test a diagnosis for Alzheimer’s?

No. It is not a stand-alone diagnostic test. It’s used as one piece of information within a full neurology evaluation to help guide next steps.

Is this test used as a general screening test for everyone?

No. The pTau-217 test is not meant for “just checking” when someone has no symptoms. It’s typically considered when there are cognitive concerns and the result would help guide clinical decisions.

What does pTau-217 measure?

It measures a specific Alzheimer’s-related form of a brain protein called tau that can be detected in blood. Higher levels can suggest Alzheimer’s-type changes may be more likely, but results must be interpreted in context.

Who is a good candidate for this test?

Adults with memory or cognitive changes, patients already being evaluated for dementia, and patients referred by a PCP for specialist assessment may be candidates. A neurologist decides whether it’s appropriate based on the full clinical picture.

How is this different from a spinal tap or PET scan?

A blood test is less invasive and easier to access. Spinal taps and specialized PET scans may still be used in certain situations, but blood-based biomarkers can sometimes help clarify whether those steps are needed.

What should I do if I’m worried about memory changes?

Schedule a neurology evaluation. A specialist can assess symptoms, review your history and medications, and determine which tests are appropriate, including whether pTau-217 testing makes sense.